03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Professor Sarah Smith: no photograph is held, so the academic plate is shown instead.
Academic
Professor Sarah Smith
Centre for Dementia Research academic
0
0
0
1
0
0
0
0
0
0
0
0
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
2
press citations on 2 topics since 13 Aug 2025 · last quoted 27 Mar 2026
02 Quoted on · 2 of 29 topics
Professor Sarah Smith: key facts
- Kind of voice
- Academic
- Role
- Centre for Dementia Research academic
- Quoted on
- Rare diseases, Dementia
- Tracked press citations
- 2
- Most recently quoted
- 27 Mar 2026
- First quoted
- 13 Aug 2025
04 The signal · where Professor Sarah Smith sits on rare diseases
Ranked 3= of 100 voices quoted in the press on rare diseases, level with 1 other on 7 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 3=Professor Sarah SmithAcademicCentre for Dementia Research academic7
- 5Dr Rich ScottSector leaderChief Executive Officer of Genomics England6
- 6=Andy FletcherSector leaderChief Executive Officer, Muscular Dystrophy UK5
Showing ranks 1 to 6 of 100 voices · See every voice on the topic →
05 On the record · press
What Professor Sarah Smith has said
By outlet · linked articles
- carehomeprofessional.com1
- nursingtimes.net1
Where Professor Sarah Smith has been quoted
- 01Scotland to trial screening babies for spinal muscular atrophy | Nursing Timesnursingtimes.net · 27 Mar 2026
- 02Dementia researchers call for help from adult social care providerscarehomeprofessional.com · 13 Aug 2025
Verbatim
“Our staff have worked tirelessly to begin screening as quickly as possible, so we can start to understand the impact that earlier treatment may have on babies born with this condition.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 11 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.